RPS7P15

Across TCGA pan-cancer cohorts, RPS7P15 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RPS7P15 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS7P15 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS7P15 expression acts as an unfavorable survival marker, although some lineages such as CESC and LAML show a favorable association.

ACC, CESC, and LAML are the cancer types where RPS7P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	II,III,IV	0.536	0.849	<.001	70	view →
CESC	DFS	Tertile	All	0.734	0.407	.001	26	view →
LAML	DFS	Tertile	All	0.681	0.440	.006	24	view →
LUSC	OS	Median	All	0.805	0.715	.006	22	view →
UCEC	DFS	Quartile	All	0.928	0.846	.008	18	view →
CHOL	OS	Tertile	II,III,IV	0.024	0.601	.025	18	view →
OV	DFS	Median	IV	0.558	0.365	.010	18	view →
SKCM	DFS	Median	All	0.670	0.574	.016	14	view →
READ	DFS	Tertile	III,IV	0.902	0.479	.001	12	view →
PCPG	DFS	Median	All	1.000	0.726	.012	11	view →
BRCA	DFS	Quartile	II,III,IV	0.486	0.548	.013	8	view →
COAD	DFS	Tertile	II,III,IV	0.686	0.456	.020	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RPS7P15–ACC (OS)

Open the ACC breakdown →